Hematology/Oncology News

In this edition, low education level raises follow-up risk in screening program, screening judgement strongly influenced by clinicians and more.

A model using both clinical and imaging data predicted the absence of high-risk varices in patients with unresectable hepatocellular carcinoma and may help avoid unnecessary upper endoscopy in low-risk patients, research showed.

The lack of surgical instruments tailored for women’s hands is just one example of the gender inequity female surgeons face in the workforce.

Combining gut microbiome manipulation with immunotherapy and tyrosine kinase inhibitor therapy conveyed clinical benefit for patients with metastatic renal cell carcinoma, results of a randomized phase 1 trial showed.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, discusses the results of the PNOC005 trial she presented at International Symposium on Pediatric Neuro-Oncology.

An analysis of patients with head and neck squamous cell carcinoma who received immune checkpoint inhibitors showed those with obesity survived longer than those with normal BMI.

Researchers at Boston Medical Center identified a new small molecule that could benefit people with sickle cell disease who do not respond to hydroxyurea.

The Women in Medicine Summit, taking place Sept. 13 and 14, in Chicago, will provide attendees skill building, networking and other opportunities to amplify women in medicine and work toward gender equity in health care.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, discusses the results of the PNOC016 trial she presented at International Symposium on Pediatric Neuro-Oncology.

Bariatric surgery did not reduce risk for obesity-related cancer or cardiovascular disease compared with nonoperative treatment among adults aged at least 60 years, according to results of a population-based cohort study.